Pregnant Women Injected With Banned, Blacklisted Pharma Company’s Shot; Five Women Lose Memory And..

In a shocking incident in Gujarat, five pregnant women reportedly lost their memory after receiving injections from a blacklisted pharmaceutical company. The case of gross negligence occurred at Sanjay Gandhi Medical College in Rewa. According to reports, the women were administered a medicine that had already been banned and blacklisted. Following the injection, all five women began exhibiting symptoms of memory loss. An initial investigation suggests the injection was mistakenly issued by the hospital’s storekeeper.

The First Complaint Came From Vidisha

A complaint regarding this injection was first received from Vidisha Medical College in October 2024, after which the medicine was banned. Gujarat-based Radiant Parenterals Limited company was officially blacklisted following the report in December. Reports suggests that the pharmacist had issued the banned medicine, and appropriate action has been taken against him.

Gujarat-based Radiant Parenterals Limited

The storekeeper has been suspended in connection with the incident, but no action has been taken against other officials so far. Due to this negligence, the pharmaceutical company has also been fined and blacklisted. The incident occurred at Sanjay Gandhi Medical College in Rewa.

What Happened At Sanjay Gandhi Medical College

At Sanjay Gandhi Medical College in Rewa, five pregnant women were administered an anesthesia injection manufactured by Gujarat-based Radiant Parenterals Limited. The company had already been blacklisted in December due to poor quality standards of its injections.

Banned Injection Issued By Storekeeper

The investigation revealed that hospital storekeeper Praveen Upadhyay mistakenly issued the banned injection, leading to his suspension. However, despite the gravity of the incident, no action was taken against other responsible officials. The probe also uncovered serious lapses in medicine storage—temperature was not properly monitored, inventory records were poorly maintained, and expired or substandard drugs were stored alongside approved ones.

Gujarat-based Radiant Parenterals Limited Banned For 5 Years

The company has been debarred from undertaking any government contracts for five years and blacklisted for two years. Additionally, a fine of ₹3.01 lakh has been imposed on the company. The use of the injection produced by Radiant Parenterals Limited was banned.

Related Posts

Dr Reddy’s set to start selling generic Ozempic in India at potentially half price

The prices of Ozempic in India can potentially halve to ₹3,600 after Dr. Reddy’s and its ilk start producing the generic version of semaglutide, Nomura says. Dr Reddy’s Laboratories Ltd. is…

A total of 167 drug samples flagged as ‘not of standard quality’ in December 2025: Health Ministry

The list of NSQ and spurious drugs is put up on the CDSCO portal on a monthly basis as part of routine regulatory surveillance activity “As many as 167 drug…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Dr Reddy’s set to start selling generic Ozempic in India at potentially half price

Dr Reddy’s set to start selling generic Ozempic in India at potentially half price

A total of 167 drug samples flagged as ‘not of standard quality’ in December 2025: Health Ministry

A total of 167 drug samples flagged as ‘not of standard quality’ in December 2025: Health Ministry

Union Minister Anupriya Patel launches NBEMS online AI training programme for doctors

Union Minister Anupriya Patel launches NBEMS online AI training programme for doctors

English alphabets can’t be trademarked: Delhi HC

English alphabets can’t be trademarked: Delhi HC

IIT Roorkee develops next-generation antibody discovery platform

IIT Roorkee develops next-generation antibody discovery platform

CDSCO approves highest number of new drugs with r-DNA origin for import & manufacture in 2025

CDSCO approves highest number of new drugs with r-DNA origin for import & manufacture in 2025